Introduction

This page provides a comprehensive analysis of the known insider trading history of Thomas H Glocer. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Thomas H Glocer has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:MS / Morgan Stanley Director 119,288
US:MRK / Merck & Co., Inc. Director 80,715
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Thomas H Glocer. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Thomas H Glocer as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-06-03 2025-06-01 4 MS MORGAN STANLEY
Common Stock
A - Award 843 119,288 0.71 127.58 107,500 15,219,189
2025-06-03 2025-06-01 4 MS MORGAN STANLEY
Common Stock
A - Award 2,155 118,446 1.85
2024-12-03 2024-12-01 4 MS MORGAN STANLEY
Common Stock
A - Award 757 114,772 0.66 132.04 100,000 15,153,964
2024-06-03 2024-06-01 4 MS MORGAN STANLEY
Common Stock
A - Award 1,029 112,267 0.93 97.19 100,000 10,910,711
2024-06-03 2024-06-01 4 MS MORGAN STANLEY
Common Stock
A - Award 2,675 111,238 2.46
2023-12-04 2023-12-01 4 MS MORGAN STANLEY
Common Stock
A - Award 1,247 106,670 1.18 80.20 100,000 8,555,435
2023-06-02 2023-06-01 4 MS MORGAN STANLEY
Common Stock
A - Award 1,218 103,375 1.19 82.08 100,000 8,484,523
2023-06-02 2023-06-01 4 MS MORGAN STANLEY
Common Stock
A - Award 3,168 102,157 3.20
2023-05-05 2023-05-03 4 MS MORGAN STANLEY
Common Stock
S - Sale -4,535 98,110 -4.42 87.10 -395,021 8,545,904
2022-12-02 2022-12-01 4 MS MORGAN STANLEY
Common Stock
A - Award 862 101,925 0.85 92.81 80,000 9,459,996
2022-06-03 2022-06-01 4 MS MORGAN STANLEY
Common Stock
A - Award 942 99,516 0.96 84.90 80,000 8,449,006
2022-06-03 2022-06-01 4 MS MORGAN STANLEY
Common Stock
A - Award 2,945 98,574 3.08
2022-04-01 2022-03-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 137 80,715 0.17 82.05 11,250 6,622,641
2022-01-04 2021-12-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 147 79,894 0.18 76.64 11,250 6,123,099
2021-12-03 2021-12-01 4 MS MORGAN STANLEY
Common Stock
A - Award 825 94,283 0.88 96.92 80,000 9,137,616
2021-10-01 2021-09-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 116 79,122 0.15 75.11 8,750 5,942,830
2021-07-02 2021-06-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 113 78,358 0.14 77.77 8,750 6,093,886
2021-06-03 2021-06-01 4 MS MORGAN STANLEY
Common Stock
A - Award 865 92,287 0.95 92.49 80,000 8,535,788
2021-06-03 2021-06-01 4 MS MORGAN STANLEY
Common Stock
A - Award 2,703 91,422 3.05
2021-06-02 2021-05-28 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 2,635 75,916 3.60 75.89 200,000 5,761,294
2020-12-03 2020-12-01 4 MS MORGAN STANLEY
Common Stock
A - Award 1,265 87,991 1.46 63.25 80,000 5,565,106
2020-06-03 2020-06-01 4 MS MORGAN STANLEY
Common Stock
A - Award 1,788 85,677 2.13 44.74 80,000 3,833,360
2020-06-03 2020-06-01 4 MS MORGAN STANLEY
Common Stock
A - Award 5,588 83,889 7.14
2020-06-02 2020-05-29 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 2,478 71,001 3.62 80.72 200,000 5,731,172
2020-04-02 2020-03-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 227 67,997 0.34 76.94 17,500 5,231,668
2020-01-03 2019-12-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 186 67,307 0.28 90.95 16,875 6,121,586
2019-12-02 2019-12-01 4 MS MORGAN STANLEY
Common Stock
A - Award 1,614 77,162 2.14 49.57 80,000 3,824,829
2019-10-02 2019-09-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 200 66,688 0.30 84.18 16,875 5,613,820
2019-07-02 2019-06-28 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 201 66,057 0.31 83.85 16,875 5,538,865
2019-06-04 2019-06-01 4 MS MORGAN STANLEY
Common Stock
A - Award 1,955 74,419 2.70 40.92 80,000 3,045,103
2019-06-04 2019-06-01 4 MS MORGAN STANLEY
Common Stock
A - Award 6,110 72,464 9.21
2019-06-04 2019-05-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 2,336 65,856 3.68 79.21 185,000 5,216,420
2019-04-02 2019-03-29 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 406 63,095 0.65 83.17 33,750 5,247,622
2019-02-04 2019-02-04 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2019-02-04 2019-02-04 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2019-02-04 2019-02-04 4 MRK Merck & Co., Inc.
Common Stock
S - Sale -10,000 5,100 -66.23 75.96 -759,590 387,391
2019-02-04 2019-02-04 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 5,000 15,100 49.50 24.30 121,500 366,930
2019-02-04 2019-02-04 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 5,000 10,100 98.04 35.19 175,950 355,419
2019-01-03 2018-12-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 442 62,242 0.71 76.41 33,750 4,755,914
2018-12-04 2018-12-01 4 MS MORGAN STANLEY
Common Stock
A - Award 1,638 65,497 2.56 44.27 72,500 2,899,755
2018-10-02 2018-09-28 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 476 61,389 0.78 70.94 33,750 4,354,915
2018-07-02 2018-06-29 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 556 60,449 0.93 60.70 33,750 3,669,280
2018-05-29 2018-05-24 4 MS MORGAN STANLEY
Common Stock
A - Award 1,349 63,085 2.19 53.74 72,500 3,390,175
2018-05-29 2018-05-24 4 MS MORGAN STANLEY
Common Stock
A - Award 4,652 61,736 8.15
2018-05-29 2018-05-25 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 3,131 59,893 5.52 59.09 185,000 3,539,101
2018-04-03 2018-04-02 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 634 56,262 1.14 53.27 33,750 2,997,086
2018-01-03 2017-12-29 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 578 55,166 1.06 56.27 32,500 3,104,200
2017-11-27 2017-11-22 4 MS MORGAN STANLEY
Common Stock
A - Award 1,201 56,616 2.17 49.25 59,167 2,788,486
2017-11-09 2017-11-08 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2017-11-09 2017-11-08 4 MRK Merck & Co., Inc.
Common Stock
S - Sale -5,000 5,100 -49.50 56.20 -280,982 286,602
2017-11-09 2017-11-08 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 5,000 10,100 98.04 38.04 190,200 384,204
2017-10-02 2017-09-29 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 508 54,198 0.95 64.03 32,500 3,470,276
2017-07-05 2017-06-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 507 53,295 0.96 64.09 32,500 3,415,690
2017-05-30 2017-05-26 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 2,619 52,788 5.22 64.92 170,000 3,427,004
2017-05-24 2017-05-22 4 MS MORGAN STANLEY
Common Stock
A - Award 1,258 54,882 2.35 41.73 52,500 2,290,123
2017-05-24 2017-05-22 4 MS MORGAN STANLEY
Common Stock
A - Award 5,991 53,624 12.58
2017-04-04 2017-03-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 511 49,803 1.04 63.54 32,500 3,164,453
2017-01-03 2016-12-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 552 48,919 1.14 58.87 32,500 2,879,861
2016-11-18 2016-11-17 4 MS MORGAN STANLEY
Common Stock
A - Award 1,322 47,251 2.88 39.71 52,500 1,876,361
2016-10-04 2016-09-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 521 48,019 1.10 62.41 32,500 2,996,856
2016-07-01 2016-06-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 564 47,137 1.21 57.61 32,500 2,715,570
2016-05-31 2016-05-27 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 3,010 46,573 6.91 56.48 170,000 2,630,442
2016-05-19 2016-05-17 4 MS MORGAN STANLEY
Common Stock
A - Award 2,000 45,443 4.60 26.25 52,491 1,192,685
2016-05-19 2016-05-17 4 MS MORGAN STANLEY
Common Stock
A - Award 9,525 43,443 28.08
2016-04-04 2016-03-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 614 43,210 1.44 52.91 32,500 2,286,216
2016-01-04 2015-12-31 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 544 42,220 1.31 52.82 28,750 2,230,058
2015-11-20 2015-11-19 4 MS MORGAN STANLEY
Common Stock
A - Award 1,535 33,535 4.80 34.20 52,500 1,146,953
2015-10-01 2015-09-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 582 41,316 1.43 49.39 28,750 2,040,592
2015-07-01 2015-06-30 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 505 40,421 1.27 56.93 28,750 2,301,144
2015-06-01 2015-05-29 4 MRK Merck & Co., Inc.
Phantom Stock
A - Award 2,463 39,916 6.58 60.89 150,000 2,430,460
2015-05-21 2015-05-19 4 MS MORGAN STANLEY
Common Stock
A - Award 1,316 31,742 4.32 38.64 50,833 1,226,482
2015-05-21 2015-05-19 4 MS MORGAN STANLEY
Common Stock
A - Award 6,470 30,426 27.01
2014-11-14 2014-11-13 4 MS MORGAN STANLEY
Common Stock
A - Award 1,257 23,744 5.59 35.80 45,000 850,138
2014-06-03 2014-05-30 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 2,592 36,345 7.68 57.86 150,000 2,102,912
2014-05-15 2014-05-13 4 MS MORGAN STANLEY
Common Stock
A - Award 1,397 22,381 6.66 30.42 42,500 680,783
2014-05-15 2014-05-13 4 MS MORGAN STANLEY
Common Stock
A - Award 8,219 20,984 64.39
2013-11-15 2013-11-14 4 MS MORGAN STANLEY
Common Stock
A - Award 1,408 12,728 12.43
2013-06-03 2013-05-31 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 3,212 32,601 10.93 46.70 150,000 1,522,467
2013-05-16 2013-05-14 4 MS MORGAN STANLEY
Common Stock
A - Award 10,301 11,301 1,030.11
2013-05-16 3 MS MORGAN STANLEY
Common Stock
1,000
2012-05-29 2012-05-25 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 3,995 28,277 16.45 37.55 150,000 1,061,794
2012-04-03 2012-03-30 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 651 24,029 2.78 38.40 25,000 922,699
2012-01-04 2011-12-30 4 MRK Merck & Co. Inc.
Phantom Stock
A - Award 663 23,132 2.95 37.70 25,000 872,067
2010-08-06 2010-08-04 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
A - Award 5,000 5,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)